| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.074 | 0.01 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.01 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.11 | 0.02 |